NCT00708045View on ClinicalTrials.gov

A Multi-modality Imaging Assessment of Chemobrain

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 9, 2007

Primary Completion Date

February 5, 2015

Study Completion Date

February 5, 2015

Conditions
Cancer
Interventions
DRUG

[18F]fluoro-2-deoxy-D-glucose (FDG)

Brain scan with imaging tracer to assess brain tumor metabolism

Trial Locations (1)

84112

Huntsman Cancer Institute, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT00708045 - A Multi-modality Imaging Assessment of Chemobrain | Biotech Hunter | Biotech Hunter